Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study

OBJECTIVE: The aim of this study was to evaluate the safety of mesenchymal stem cell infusion in patients with autoimmune diseases. METHODS: A total of 404 patients with autoimmune diseases who received mesenchymal stem cell infusion between 2007 and 2016 were included in this study. Adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jun, Zhang, Huayong, Kong, Wei, Deng, Wei, Wang, Dandan, Feng, Xuebing, Zhao, Cheng, Hua, Bingzhu, Wang, Hong, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236873/
https://www.ncbi.nlm.nih.gov/pubmed/30428931
http://dx.doi.org/10.1186/s13287-018-1053-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236873/
https://www.ncbi.nlm.nih.gov/pubmed/30428931
http://dx.doi.org/10.1186/s13287-018-1053-4

Ejemplares similares